VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

caracterización × monoclonal antibody ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

Physicochemical Characterization of a new anti-PD1 Monoclonal Antibody biosimilar candidate of nivolumab obtained in CHO-K1 cell line.
Roberto Machado Santisteban

anticuerpo monoclonal biosimilar caracterización characterization monoclonal antibody

Characterization of the RBD-hFc fusion protein used in diagnostics for COVID-19 UMELISA SARS-CoV-2-IgG
Ingrid Ruiz

analytical techniques caracterización characterization fusion protein protein proteína proteína de fusión rbd-hfc técnicas analíticas

Colorimetric bioassay to determine the potency of the anti-EGFR monoclonal antibody.
Lic. Dainelis Torres Rabasa

anticuerpo monoclonal bioassay validation monoclonal antibody nimotuzumab validación de bioensayo

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)